MedPath

Comparative Study of Menstrual Blood and Systemic Blood

Completed
Conditions
Retention; Menstruation
Registration Number
NCT02740816
Lead Sponsor
Stanford University
Brief Summary

The purpose is to investigate how menstrual blood differs from systemic blood to evaluate if menstrual blood could be utilized as a natural and non-invasive access to blood for regular health monitoring and early diagnostics.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
35
Inclusion Criteria
  • Age 18-45
Exclusion Criteria
  • weigh less then 110 pounds
  • currently on a birth control method

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Health Markers in Systemic Blood vs. Menstrual BloodUp to 2 months

The following biomarkers will be tested for and then compared for systemic blood and menstrual blood:

* BUN

* Sodium

* Potassium

* Chloride

* Glucose

* Calcium

* HDL

* LDL

* Triglycerides

* CRP

* Estradiol

* Ferritin

* A1c

* Hemoglobin

* Hepatic function panel

* TSH

* FSH

* T3

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath